Targeting disease-specific autoreactive T cells with Kv1.3 blockers: A new therapy for autoimmune diseases

被引：0
|
作者：
Wulff, H
Mullen, K
Beeton, C
Wang, P
Counts, D
Calabresi, PA
Chandy, KG
机构：
[1] Univ Calif Davis, Davis, CA 95616 USA
[2] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[3] Univ Calif Irvine, Irvine, CA USA
来源：
BIOPHYSICAL JOURNAL | 2005年 / 88卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：21A / 21A
页数：1
相关论文
共 50 条
  • [21] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels: implication for multiple sclerosis therapy
    Beeton, C
    Pennington, MW
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Langer, J
    Calabresi, P
    Chandy, KG
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 279A - 279A
  • [22] Engineering a Potent and Specific Blocker of Voltage-Gated Potassium Channel Kv1.3, a Target for Autoimmune Diseases
    Chen, Rong
    Chung, Shin-Ho
    BIOCHEMISTRY, 2012, 51 (09) : 1976 - 1982
  • [23] Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases
    Schmitz, A
    Sankaranarayanan, A
    Azam, P
    Schmidt-Lassen, K
    Homerick, D
    Hänsel, W
    Wulff, H
    MOLECULAR PHARMACOLOGY, 2005, 68 (05) : 1254 - 1270
  • [24] Controlled release of a structured polypeptide through polymeric depot formulation of ShK-186/-192, selective blockers of Kv1.3 channels on autoreactive memory T cells
    Chesko, James D.
    Norton, Kayla
    Grigg, John
    Londono, Luz M.
    Iodonato, Shawn P.
    Munoz, Ernesto J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [25] A small molecule Kv1.3 blocker, for the treatment of effector memory T-cell mediated autoimmune diseases.
    Azam, Philippe
    Sankaranarayanan, Ananthakrishnan
    Homerick, Daniel
    Wulff, Heike
    CLINICAL IMMUNOLOGY, 2006, 119 : S45 - S46
  • [26] Kv1.3 blockers ameliorate allergic contact dermatitis by preferentially suppressing effector memory T cells in a rat model
    Ueyama, A.
    Imura, K.
    Kasai-Yamamoto, E.
    Tai, N.
    Nagira, M.
    Shichijo, M.
    Yasui, K.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (08) : 897 - 903
  • [27] Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis
    Gocke, Anne R.
    Lebson, Lori A.
    Grishkan, Inna V.
    Hu, Lina
    Nguyen, Hai M.
    Whartenby, Katharine A.
    Chandy, K. George
    Calabresi, Peter A.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (12): : 5877 - 5886
  • [28] Targeting the Mitochondrial Potassium Channel Kv1.3 to Kill Cancer Cells: Drugs, Strategies, and New Perspectives
    Prosdocimi, Elena
    Checchetto, Vanessa
    Leanza, Luigi
    SLAS DISCOVERY, 2019, 24 (09) : 882 - 892
  • [29] Autoimmune disease-specific TCR repertoires in peripheral blood T cells
    Stys, P.
    Barennes, P.
    Barbie, M.
    Lorenzon, R.
    Surroque, M.
    Roux, A.
    Rozenzwagj, M.
    Six, A.
    Mariotti-Ferrandiz, E.
    Klatzmann, D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 287 - 287
  • [30] Adjuvant guided differentiation of autoreactive T cells for the therapy of autoimmune disease.
    Forsthuber, T
    Cheng, H
    Lehmann, PV
    FASEB JOURNAL, 1996, 10 (06): : 1780 - 1780
12345